Platform Snapshot & Services
American HealthCare Capital is the exclusive advisor for a multi-site behavioral health platform based in the Northeastern United States. The organization delivers a broad mix of services: individual, couples, and group therapy, talk therapy, ADHD care, TMS, Spravato, diagnostic evaluations and assessments, and medication management. The group also supports enterprise clients operating in high-intensity corporate settings and correctional facilities.
Care is delivered through seven brick-and-mortar clinics, with two additional practices under LOI, complemented by an extensive telehealth footprint.
Patients & Access
The platform actively serves six thousand patients. Daily throughput averages roughly 200 visits, with about 10% first-time appointments. The patient mix is approximately 93% adults and 7% pediatric, supported by licensed clinicians focused on measurable quality-of-life improvements.
Financial Summary
- Payor mix: 88% Commercial, 6% Medicare, 6% Self-Pay.
- Revenue trajectory: $2.5M (2024), $4.7M (2025E), $7.6M (2026E).
- Profitability: EBITDA of $0.4M (2024), $0.8M (2025E), and $1.3M (2026E).
- Mid-year performance: gross revenue up 60% YTD (through Q2 2025) vs. 2024.
Even without incremental growth investment, the platform is positioned to deliver a +20% EBITDA margin. Management plans to continue opening new clinics. At scale, anticipated production from new locations and hires is 350 daily visits and $10 million in revenue, excluding contributions from TMS and Spravato.
Growth Plan & Market Position
Signed pipeline of add-ons and over 10 locations targeted in active review supports a regional roll-up. Demand for behavioral health continues to rise, with waitlists validating market need. Active recruiting across Psychiatrists, NPs, PAs, Psychologists, and Therapists sustains access and growth. Established local brand recognition provides a strong base for further market penetration.
Team & Leadership
Approximately 70 team members power the platform, including around 40 clinicians and 30 non-clinical professionals (including centralized RCM, credentialing, CRM, digital/web, bookkeeping, and software). The physician-founder and CEO, a seasoned clinical entrepreneur with a prior platform exit to mid-market PE, intends to remain in place to drive scale and partner on a future exit. The full team is expected to stay on post-investment.
Transaction Considerations
Investment Highlights:
- Expansion runway: over 10 locations and a few add-on locations under LOI.
- Strong demand signal: persistent waitlist for new intakes across markets.
- Rapid financial momentum: 60% YoY gross revenue growth as of Q2 2025.
- Experienced leadership: physician-founder previously built and exited a Mid-Atlantic mental health platform to a respected mid-market PE buyer.
- Scalable operating engine: integrated RCM, marketing, customer experience, and technology.
Asking Price and Deal Structure
The company is seeking a strategic or capital partner with the resources to accelerate growth. Valuation will be determined through negotiations and will exclude accounts receivable, cash, and any real estate. The seller is open to flexible structures, including a majority recapitalization with rolling equity.
